Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs.

MLA

Salzano, Giuseppina, et al. “Cyclodextrin-Based Nanocarriers Containing a Synergic Drug Combination: A Potential Formulation for Pulmonary Administration of Antitubercular Drugs.” International Journal of Pharmaceutics, vol. 531, no. 2, Oct. 2017, pp. 577–87. EBSCOhost, https://doi.org/10.1016/j.ijpharm.2017.05.030.

APA

Salzano, G., Wankar, J., Ottani, S., Villemagne, B., Baulard, A. R., Willand, N., Brodin, P., Manet, I., & Gref, R. (2017). Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs. International Journal of Pharmaceutics, 531(2), 577–587. https://doi.org/10.1016/j.ijpharm.2017.05.030

Chicago

Salzano, Giuseppina, Jitendra Wankar, Stefano Ottani, Baptiste Villemagne, Alain R Baulard, Nicolas Willand, Priscille Brodin, Ilse Manet, and Ruxandra Gref. 2017. “Cyclodextrin-Based Nanocarriers Containing a Synergic Drug Combination: A Potential Formulation for Pulmonary Administration of Antitubercular Drugs.” International Journal of Pharmaceutics 531 (2): 577–87. doi:10.1016/j.ijpharm.2017.05.030.